D'ANDREA, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 242
NA - Nord America 187
AS - Asia 49
Totale 478
Nazione #
US - Stati Uniti d'America 187
IT - Italia 124
IE - Irlanda 46
SG - Singapore 25
SE - Svezia 23
DE - Germania 21
RU - Federazione Russa 11
CN - Cina 7
HK - Hong Kong 7
FI - Finlandia 6
TR - Turchia 4
IN - India 3
BE - Belgio 2
CZ - Repubblica Ceca 2
FR - Francia 2
GB - Regno Unito 2
NL - Olanda 2
VN - Vietnam 2
CH - Svizzera 1
KZ - Kazakistan 1
Totale 478
Città #
Dublin 44
Chandler 43
Ashburn 25
Munich 19
Milan 17
Singapore 15
Rome 14
Princeton 12
Chicago 9
Chieti 7
Hong Kong 6
Washington 6
Lappeenranta 5
Los Angeles 5
Altamura 4
Boardman 4
San Potito Sannitico 4
Lenno 3
Pescara 3
Reggio Calabria 3
Ankara 2
Augusta 2
Bologna 2
Brussels 2
Campi Bisenzio 2
Carmignano 2
Casalbordino 2
Dong Ket 2
Florence 2
Frankfurt am Main 2
Istanbul 2
Naples 2
New York 2
Olomouc 2
Penne 2
Pioltello 2
Pune 2
Sant'Egidio alla Vibrata 2
Scarsdale 2
Seattle 2
Syracuse 2
Tappahannock 2
Triuggio 2
Xiamen 2
Allumiere 1
Amsterdam 1
Ancona 1
Avezzano 1
Bari 1
Helsinki 1
Leawood 1
Lecce 1
London 1
Maastricht 1
Meyzieu 1
Montreuil 1
Mumbai 1
Norwalk 1
Perugia 1
Poplar 1
San Jose 1
SantAntioco 1
Santa Clara 1
Scandicci 1
Trieste 1
Wilmington 1
Zurich 1
Totale 319
Nome #
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 59
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 44
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 43
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 41
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 38
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 30
Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression 23
null 22
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 22
The transition time to gambling disorder: The roles that age, gambling preference and personality traits play 22
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 21
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 20
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization 18
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 17
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 16
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 15
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 14
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 14
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 13
Addiction biotypes: a paradigm shift for future treatment strategies? 13
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 13
Language proficiency and mental disorders among migrants: A systematic review 12
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions 4
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 4
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 4
Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)] 3
Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression 3
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia 2
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties? 1
Totale 551
Categoria #
all - tutte 3.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 6 2 4 0 7 2
2021/202223 1 0 0 0 1 0 0 3 4 2 2 10
2022/2023150 7 18 10 5 18 25 8 14 32 4 2 7
2023/2024311 10 19 35 16 37 44 37 29 18 16 15 35
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 551